Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

The Guardian Business

ONP 요약

Johnson & J&J has agreed to pay $5.5bn to settle nearly 70,000 U.S. lawsuits that allege its talc products caused ovarian cancer. The settlement requires acceptance by 95% of claimants before it becomes final.

진보 성향:Corporate accountability — progressive outlets highlight the settlement as a step toward justice for cancer victims and emphasize the 95% acceptance requirement.

중도 성향:Legal resolution — moderate outlets report the settlement as a formal closure of a long-running litigation over talc-related cancer claims.

보수 성향:Business reassurance — conservative outlets frame the settlement as a routine corporate decision and stress J&J’s confidence in product safety.

Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle

Johnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby ⁠powder and other talc products caused ⁠ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle.

Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, ⁠representing nearly all of the remaining talc claims against the company.
Continue reading...

전문 보기